BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV 20.05% 41.93% 51.59% 42.58% 20.67% 9.55% 2.60% 0.91% 15.79% 04/07/2010
BIB Market Price 20.06% 42.12% 51.73% 42.51% 20.92% 9.51% 2.55% 0.91% 15.79% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 11/26/2025
  • NAV
    $83.47
  • NAV Change
    $+1.41 up caret
  • Market Price
    $83.58
  • Market Price Change
    $+1.47 up caret
  • Trading Volume (M)
    23,855
  • 30-Day Median Bid Ask Spread
    0.28%
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 11/26/2025
  • NAV
    $83.47
  • NAV Change
    $+1.41 up caret
  • Market Price
    $83.58
  • Market Price Change
    $+1.47 up caret
  • Trading Volume (M)
    23,855
  • 30-Day Median Bid Ask Spread
    0.28%
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 9/30/2025

Holdings

as of 11/26/2025

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
5.28% AMGN AMGEN INC -- $4,628,264.24 13,432 2023607
4.98% GILD GILEAD SCIENCES INC -- $4,362,244.61 34,211 2369174
4.87% VRTX VERTEX PHARMACEUTICALS INC -- $4,271,136.11 9,883 2931034
4.32% REGN REGENERON PHARMACEUTICALS -- $3,785,743.25 4,825 2730190
3.08% ALNY ALNYLAM PHARMACEUTICALS INC -- $2,702,323.52 6,071 B00FWN1
2.57% AZN ASTRAZENECA PLC-SPONS ADR -- $2,256,757.56 24,183 2989044
2.30% INSM INSMED INC -- $2,018,922.72 9,872 2614487
1.50% ARGX ARGENX SE - ADR -- $1,311,293.27 1,429 BDVLM39
1.42% BIIB BIOGEN INC -- $1,245,743.18 6,847 2455965
1.18% UTHR UNITED THERAPEUTICS CORP -- $1,031,564.16 2,112 2430412
1.10% INCY INCYTE CORP -- $963,422.35 9,119 2471950
1.06% ILMN ILLUMINA INC -- $931,776.18 7,178 2613990
0.92% RPRX ROYALTY PHARMA PLC- CL A -- $804,289.92 20,188 BMVP7Y0
0.91% MEDP MEDPACE HOLDINGS INC -- $795,859.20 1,312 BDCBC61
0.80% NBIX NEUROCRINE BIOSCIENCES INC -- $701,966.98 4,631 2623911
0.77% RVMD REVOLUTION MEDICINES INC -- $677,273.40 8,730 BL71K91
0.76% ROIV ROIVANT SCIENCES LTD -- $665,565.17 31,891 BMW4NZ9
0.73% BBIO BRIDGEBIO PHARMA INC -- $640,244.44 8,927 BK1KWG8
0.72% GH GUARDANT HEALTH INC -- $627,768.96 5,824 BFXC911
0.72% MDGL MADRIGAL PHARMACEUTICALS INC -- $627,475.32 1,044 BD59BS7
0.72% SNY SANOFI-ADR -- $626,975.96 12,532 2964557
0.71% SMMT SUMMIT THERAPEUTICS INC -- $618,193.62 34,691 BMTVQS7
0.70% IONS IONIS PHARMACEUTICALS INC -- $615,536.10 7,443 BDJ0LS6
0.69% TEM TEMPUS AI INC -- $608,183.17 7,877 BSLSJJ0
0.68% ASND ASCENDIS PHARMA A/S - ADR -- $595,378.35 2,835 BV9G6B8
0.66% VTRS VIATRIS INC -- $579,305.44 54,446 BMWS3X9
0.63% EXEL EXELIXIS INC -- $555,763.91 12,571 2576941
0.61% ONC BEONE MEDICINES LTD-ADR -- $534,804.80 1,570 BYYWPW6
0.57% JAZZ JAZZ PHARMACEUTICALS PLC -- $501,037.44 2,832 B4Q5ZN4
0.57% BMRN BIOMARIN PHARMACEUTICAL INC -- $497,736.80 8,965 2437071
0.55% BNTX BIONTECH SE-ADR -- $482,484.60 4,698 BK6H543
0.52% MRNA MODERNA INC -- $454,431.70 18,170 BGSXTS3
0.49% RNA AVIDITY BIOSCIENCES INC -- $429,932.48 6,008 BMWHPY1
0.45% HALO HALOZYME THERAPEUTICS INC -- $396,868.92 5,462 2975098
0.43% CYTK CYTOKINETICS INC -- $380,822.20 5,588 BBBSBJ5
0.43% ARWR ARROWHEAD PHARMACEUTICALS IN -- $372,633.47 6,457 BYQBFJ8
0.40% AXSM AXSOME THERAPEUTICS INC -- $351,934.38 2,331 BYZR4X4
0.39% NUVL NUVALENT INC-A -- $339,612.84 3,114 BMVBZD3
0.39% MRUS MERUS NV -- $339,389.88 3,532 BZBY005
0.38% RYTM RHYTHM PHARMACEUTICALS INC -- $333,216.84 3,102 BF2YWG4
0.37% PTCT PTC THERAPEUTICS INC -- $319,987.50 3,710 B17VCN9
0.34% PCVX VAXCYTE INC -- $301,027.95 6,063 BKPVGH6
0.34% KRYS KRYSTAL BIOTECH INC -- $295,463.70 1,351 BD6JX35
0.30% COGT COGENT BIOSCIENCES INC -- $263,504.36 6,524 BLR6XK8
0.30% PTGX PROTAGONIST THERAPEUTICS INC -- $261,653.35 2,905 BDCBCD8
0.26% ALKS ALKERMES PLC -- $229,111.48 7,709 B3P6D26
0.26% KYMR KYMERA THERAPEUTICS INC -- $226,584.54 3,339 BMPRZV5
0.26% CRSP CRISPR THERAPEUTICS AG -- $225,992.00 4,240 BDHF4K6
0.25% -- NEWAMSTERDAM PHARMA CO NV -- $217,985.55 5,259 BP8JSP4
0.24% ADMA ADMA BIOLOGICS INC -- $213,296.16 11,144 B9NSBM2
0.23% AKRO AKERO THERAPEUTICS INC -- $203,051.60 3,736 BK7Y2V9
0.23% CRNX CRINETICS PHARMACEUTICALS IN -- $202,439.94 4,398 BDD19F8
0.22% ACAD ACADIA PHARMACEUTICALS INC -- $195,477.99 7,879 2713317
0.22% INDV INDIVIOR PLC -- $195,087.96 5,827 BP0BQQ5
0.22% SRRK SCHOLAR ROCK HOLDING CORP -- $193,743.50 4,490 BFZQ0L8
0.22% IMVT IMMUNOVANT INC -- $192,918.00 8,140 BJRFSB7
0.22% ACLX ARCELLX INC -- $189,717.50 2,590 BPCJ1Q2
0.22% LGND LIGAND PHARMACEUTICALS -- $188,636.40 915 2501578
0.21% GRAL GRAIL INC -- $185,509.44 1,684 BSLSSX7
0.21% PRAX PRAXIS PRECISION MEDICINES I -- $185,334.82 983 BQ721R4
0.21% AMRX AMNEAL PHARMACEUTICALS INC -- $183,630.84 14,667 BFNF1D6
0.20% VCYT VERACYTE INC -- $175,286.54 3,674 BFTWZY0
0.20% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $173,252.16 5,596 BKX9VD3
0.20% MIRM MIRUM PHARMACEUTICALS INC -- $171,562.98 2,346 BJDX8Y8
0.18% XENE XENON PHARMACEUTICALS INC -- $160,208.49 3,601 BRJ3GY4
0.18% CGON CG ONCOLOGY INC -- $159,675.24 3,561 BRBCSP4
0.18% TARS TARSUS PHARMACEUTICALS INC -- $158,665.50 1,971 BMH5RL1
0.17% IRON DISC MEDICINE INC -- $152,062.50 1,622 BMGJZJ8
0.17% RARE ULTRAGENYX PHARMACEUTICAL IN -- $151,953.76 4,501 BJ62Z18
0.17% APGE APOGEE THERAPEUTICS INC -- $151,620.06 2,154 BM9HHL5
0.17% TVTX TRAVERE THERAPEUTICS INC -- $150,914.12 4,162 BLFGJD5
0.17% IDYA IDEAYA BIOSCIENCES INC -- $146,820.96 4,092 BK0VHF6
0.16% FOLD AMICUS THERAPEUTICS INC -- $144,237.90 14,395 B19FQ48
0.16% DYN DYNE THERAPEUTICS INC -- $140,632.31 6,643 BN15WD1
0.16% ADPT ADAPTIVE BIOTECHNOLOGIES -- $140,228.92 7,111 BJ5FZ74
0.15% MLYS MINERALYS THERAPEUTICS INC -- $134,242.56 3,096 BP9N0G0
0.15% DNLI DENALI THERAPEUTICS INC -- $132,482.60 6,829 BD2B4V0
0.15% CNTA CENTESSA PHARMACEUTICALS-ADR -- $129,772.44 4,478 BLB0YQ9
0.15% APLS APELLIS PHARMACEUTICALS INC -- $127,337.82 5,898 BYTQ6X1
0.14% EWTX EDGEWISE THERAPEUTICS INC -- $125,558.40 4,920 BKY5JZ8
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $121,154.94 2,619 B72ZBG4
0.13% BEAM BEAM THERAPEUTICS INC -- $118,266.75 4,725 BK6L288
0.13% TERN TERNS PHARMACEUTICALS INC -- $117,328.75 4,081 BMDJ0C9
0.12% LEGN LEGEND BIOTECH CORP-ADR -- $108,130.00 3,932 BMX9K07
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $100,626.39 6,147 BFWLC09
0.11% TXG 10X GENOMICS INC-CLASS A -- $100,181.25 5,343 BKS3RS7
0.11% VERA VERA THERAPEUTICS INC -- $99,323.40 2,980 BL55460
0.11% OCUL OCULAR THERAPEUTIX INC -- $98,637.50 8,125 BNZB1X8
0.11% JANX JANUX THERAPEUTICS INC -- $97,340.14 2,806 BMFX8Y7
0.11% AVDL AVADEL PHARMACEUTICALS -- $97,027.60 4,534 BDGMC59
0.11% ZYME ZYMEWORKS INC -- $95,928.30 3,510 BPCQZY9
0.11% SRPT SAREPTA THERAPEUTICS INC -- $95,615.80 4,564 B8DPDT7
0.11% HRMY HARMONY BIOSCIENCES HOLDINGS -- $95,514.16 2,686 BKSGZN7
0.11% GPCR STRUCTURE THERAPEUTICS INC -- $95,234.26 2,783 BQS9486
0.11% VCEL VERICEL CORP -- $95,111.72 2,356 BSBMN89
0.11% IBRX IMMUNITYBIO INC -- $94,024.59 44,143 BNSP0B8
0.10% OLMA OLEMA PHARMACEUTICALS INC -- $90,124.60 3,205 BMZ4LN0
0.10% TWST TWIST BIOSCIENCE CORP -- $89,362.30 2,819 BGKG6G7
0.10% RXRX RECURSION PHARMACEUTICALS-A -- $88,005.96 19,956 BM9FJ13
0.10% KNSA KINIKSA PHARMACEUTICALS INTE -- $86,356.20 2,030 BRXB0C0
0.10% ANIP ANI PHARMACEUTICALS INC -- $85,456.68 1,013 BCDWBX6
0.10% SYRE SPYRE THERAPEUTICS INC -- $83,924.75 2,821 BQBBDY8
0.09% SNDX SYNDAX PHARMACEUTICALS INC -- $79,937.01 4,023 BN7Q7R7
0.09% STOK STOKE THERAPEUTICS INC -- $79,866.39 2,559 BJQ05Z6
0.09% AGIO AGIOS PHARMACEUTICALS INC -- $78,959.76 2,719 BCBVTX1
0.09% MNKD MANNKIND CORP -- $77,090.02 14,329 BF081J4
0.09% TRVI TREVI THERAPEUTICS INC -- $75,580.23 5,687 BJH9ZN0
0.09% ALVO ALVOTECH SA -- $75,277.55 14,617 BPNTJ34
0.09% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $75,043.10 1,870 BLCD809
0.08% HROW HARROW INC -- $71,366.40 1,728 BHNDW86
0.08% QURE UNIQURE NV -- $70,788.06 2,562 BJFSR88
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $69,608.40 9,804 2100362
0.08% COLL COLLEGIUM PHARMACEUTICAL INC -- $68,004.33 1,471 BX7RSN3
0.08% ARDX ARDELYX INC -- $66,736.22 11,254 BN89V40
0.08% NVCR NOVOCURE LTD -- $66,619.96 5,221 BYSS4X4
0.07% RLAY RELAY THERAPEUTICS INC -- $64,649.53 8,051 BN2R582
0.07% INVA INNOVIVA INC -- $63,892.53 2,943 BDDXF67
0.07% URGN UROGEN PHARMA LTD -- $63,576.62 2,161 BZ7PJQ1
0.07% DVAX DYNAVAX TECHNOLOGIES CORP -- $62,590.68 5,476 BRJZSK0
0.07% GMAB GENMAB A/S -SP ADR -- $62,499.36 1,958 BBC9WC7
0.07% AMLX AMYLYX PHARMACEUTICALS INC -- $62,415.00 4,161 BPCK358
0.07% TSHA TAYSHA GENE THERAPIES INC -- $61,911.54 12,739 BNC1BX1
0.07% NRIX NURIX THERAPEUTICS INC -- $61,369.60 3,568 BMVLGP2
0.07% ELVN ENLIVEN THERAPEUTICS INC -- $60,049.86 2,766 BMFD115
0.07% AMPH AMPHASTAR PHARMACEUTICALS IN -- $59,398.56 2,171 BNFWZS4
0.07% XNCR XENCOR INC -- $57,892.78 3,331 BGCYWN8
0.07% CVAC CUREVAC NV -- $57,622.20 10,515 BN4RD42
0.07% WVE WAVE LIFE SCIENCES LTD -- $57,003.44 7,432 BYZG9R0
0.06% INBX INHIBRX BIOSCIENCES INC -- $56,637.82 677 BNSP8K3
0.06% TNGX TANGO THERAPEUTICS INC -- $55,908.96 5,196 BP2P6L0
0.06% ANAB ANAPTYSBIO INC -- $55,145.28 1,308 BDRW1L7
0.06% TYRA TYRA BIOSCIENCES INC -- $54,832.67 2,489 BMVNDH9
0.06% XERS XERIS BIOPHARMA HOLDINGS INC -- $54,144.38 7,541 BLR7H87
0.06% CSTL CASTLE BIOSCIENCES INC -- $54,078.76 1,354 BKLCWZ3
0.06% ORIC ORIC PHARMACEUTICALS INC -- $53,603.70 4,535 BKVDFF7
0.06% FTRE FORTREA HOLDINGS INC -- $53,551.20 4,240 BRXYZ57
0.06% ORKA ORUKA THERAPEUTICS INC -- $53,274.54 1,749 BKVF0J2
0.06% NVAX NOVAVAX INC -- $52,715.75 7,585 BJDQXG4
0.06% PGEN PRECIGEN INC -- $52,042.10 13,915 BKM5C84
0.06% ABCL ABCELLERA BIOLOGICS INC -- $50,796.20 13,955 BL53SR3
0.06% PHAT PHATHOM PHARMACEUTICALS INC -- $50,258.21 3,313 BJLKVS6
0.06% RAPP RAPPORT THERAPEUTICS INC -- $50,178.15 1,705 BR3T9B6
0.06% GRFS GRIFOLS SA-ADR -- $50,019.66 5,697 B8K7T65
0.06% PCRX PACIRA BIOSCIENCES INC -- $49,953.38 2,098 B3X26D8
0.06% KURA KURA ONCOLOGY INC -- $48,595.47 4,053 BYZD465
0.06% SANA SANA BIOTECHNOLOGY INC -- $48,565.62 12,081 BMFJJ97
0.05% EYPT EYEPOINT PHARMACEUTICALS INC -- $47,609.01 3,219 BMGS7L1
0.05% TBPH THERAVANCE BIOPHARMA INC -- $46,945.92 2,352 BMNDK09
0.05% GLUE MONTE ROSA THERAPEUTICS INC -- $46,115.16 2,884 BP7KZP7
0.05% DAWN DAY ONE BIOPHARMACEUTICALS I -- $45,008.03 4,783 BLB0YH0
0.05% ZLAB ZAI LAB LTD-ADR -- $44,593.01 2,233 BD9GVY0
0.05% PSNL PERSONALIS INC -- $44,391.52 4,141 BJQ0608
0.05% SPRY ARS PHARMACEUTICALS INC -- $44,165.55 4,615 BMCR7V2
0.05% AVBP ARRIVENT BIOPHARMA INC -- $43,656.70 1,894 BMGTLY5
0.05% SVRA SAVARA INC -- $43,265.92 8,072 BYXGN81
0.05% MNMD MIND MEDICINE MINDMED INC -- $43,076.00 3,560 BPQYY97
0.05% NTLA INTELLIA THERAPEUTICS INC -- $42,710.76 5,013 BYZM6C2
0.05% RIGL RIGEL PHARMACEUTICALS INC -- $42,704.48 838 BQD3J33
0.05% ARVN ARVINAS INC -- $42,588.18 3,429 BDZ30Q0
0.05% ERAS ERASCA INC -- $41,463.11 13,247 BNLYBF3
0.05% VIR VIR BIOTECHNOLOGY INC -- $41,451.93 6,487 BK4PZ38
0.05% IOVA IOVANCE BIOTHERAPEUTICS INC -- $41,233.56 16,899 BF0DMK7
0.05% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $41,111.73 951 BL95N25
0.05% LENZ LENZ THERAPEUTICS INC -- $40,919.04 1,332 BQV0J03
0.05% ABUS ARBUTUS BIOPHARMA CORP -- $39,478.32 8,952 BZ0QMB7
0.04% MESO MESOBLAST LTD- SPON ADR -- $38,300.85 2,205 BQS7491
0.04% ESPR ESPERION THERAPEUTICS INC -- $37,193.20 9,416 BBNBTD2
0.04% REPL REPLIMUNE GROUP INC -- $36,668.70 3,645 BDDVW37
0.04% GERN GERON CORP -- $35,456.05 29,795 2370381
0.04% AQST AQUESTIVE THERAPEUTICS INC -- $35,136.78 5,649 BYVQJ96
0.04% ALMS ALUMIS INC -- $34,563.36 4,524 BPLQG36
0.04% CRMD CORMEDIX INC -- $33,639.90 3,486 BJ0LT31
0.04% PACB PACIFIC BIOSCIENCES OF CALIF -- $33,524.53 14,027 B4N8MH9
0.04% ATXS ASTRIA THERAPEUTICS INC -- $33,213.60 2,636 BMYRFN8
0.04% KROS KEROS THERAPEUTICS INC -- $33,180.00 1,896 BM7V485
0.04% KALV KALVISTA PHARMACEUTICALS INC -- $33,149.10 2,351 BD06CS0
0.04% CGEM CULLINAN THERAPEUTICS INC -- $32,378.92 2,758 BM90J52
0.04% CRVS CORVUS PHARMACEUTICALS INC -- $31,563.60 3,480 BYP80F1
0.04% RGNX REGENXBIO INC -- $31,399.68 2,368 BZ0G875
0.04% MGTX MEIRAGTX HOLDINGS PLC -- $30,807.40 3,757 BFYQFJ2
0.03% OMER OMEROS CORP -- $30,604.14 3,178 B4NB858
0.03% PRME PRIME MEDICINE INC -- $30,295.86 8,166 BPBJFM7
0.03% IRWD IRONWOOD PHARMACEUTICALS INC -- $29,278.10 7,585 B3MZ6K5
0.03% PRTA PROTHENA CORP PLC -- $26,221.02 2,514 B91XRN2
0.03% DSGN DESIGN THERAPEUTICS INC -- $24,914.83 2,659 BMFK3H6
0.03% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $24,595.48 6,757 BMCWKZ2
0.03% LXEO LEXEO THERAPEUTICS INC -- $24,286.86 2,522 BQ6C357
0.03% LXRX LEXICON PHARMACEUTICALS INC -- $24,268.53 16,971 BWFZX59
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $23,969.19 2,181 BKLXFX5
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $22,549.20 2,622 BLFBZ32
0.03% CMPS COMPASS PATHWAYS PLC -- $22,400.09 4,283 BMC3HS7
0.03% ANNX ANNEXON INC -- $22,144.32 5,126 BMVV9R5
0.03% LYEL LYELL IMMUNOPHARMA INC -- $21,920.18 898 BTNMG41
0.02% ABSI ABSCI CORP -- $21,577.47 6,983 BN94K69
0.02% ALT ALTIMMUNE INC -- $21,310.74 4,122 BFY7DC4
0.02% EOLS EVOLUS INC -- $21,267.84 3,021 BDRJH21
0.02% GLPG GALAPAGOS NV-SPON ADR -- $20,825.97 669 B292NQ7
0.02% HCM HUTCHMED CHINA-ADR -- $20,749.68 1,449 BYXV9H7
0.02% SIGA SIGA TECHNOLOGIES INC -- $20,197.76 3,344 2107437
0.02% SLDB SOLID BIOSCIENCES INC -- $19,494.32 3,637 BQHN6C7
0.02% TECX TECTONIC THERAPEUTIC INC -- $18,694.86 874 BPBPCG8
0.02% AURA AURA BIOSCIENCES INC -- $18,508.38 2,901 BP81R42
0.02% TRDA ENTRADA THERAPEUTICS INC -- $17,912.16 1,777 BP81RK8
0.02% NMRA NEUMORA THERAPEUTICS INC -- $17,319.27 7,563 BN4JN37
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $16,578.31 5,039 BDFKQ07
0.02% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $15,760.36 2,156 BKDQKM6
0.02% KYTX KYVERNA THERAPEUTICS INC -- $15,513.60 2,020 BSMLR16
0.02% AVXL ANAVEX LIFE SCIENCES CORP -- $15,482.46 4,011 BYTYP72
0.02% PYXS PYXIS ONCOLOGY INC -- $15,290.88 2,896 BLBR8D5
0.02% AMRN AMARIN CORP PLC -ADR -- $15,187.74 941 BN72KB0
0.02% SLN SILENCE THERAPEUTICS PLC-ADR -- $15,095.88 2,207 BL5B6Z1
0.02% ALLO ALLOGENE THERAPEUTICS INC -- $14,714.04 10,362 BFZNYB7
0.02% VNDA VANDA PHARMACEUTICALS INC -- $14,622.70 2,759 B12W3P6
0.02% LRMR LARIMAR THERAPEUTICS INC -- $14,109.41 3,997 BMXNGZ6
0.02% NGNE NEUROGENE INC -- $14,000.33 667 BS2F741
0.02% ENTA ENANTA PHARMACEUTICALS INC -- $13,926.06 999 B9L5200
0.02% ACIU AC IMMUNE SA -- $13,650.87 4,659 BZC0D70
0.01% AUTL AUTOLUS THERAPEUTICS PLC -- $12,831.42 9,366 BFMLGR4
0.01% FHTX FOGHORN THERAPEUTICS INC -- $12,698.40 2,640 BMF7DT9
0.01% TKNO ALPHA TEKNOVA INC -- $11,870.25 2,499 BP7L561
0.01% AVIR ATEA PHARMACEUTICALS INC -- $11,303.30 3,706 BLN9Z50
0.01% OABI OMNIAB INC -- $10,657.80 5,730 BN13S71
0.01% VYGR VOYAGER THERAPEUTICS INC -- $10,437.70 2,590 BY7RB53
0.01% EDIT EDITAS MEDICINE INC -- $10,077.60 4,199 BZ8FPH3
0.01% HUMA HUMACYTE INC -- $9,836.68 7,396 BMYTJP4
0.01% PEPG PEPGEN INC -- $9,329.88 1,532 BMTX3D7
0.01% RNAC CARTESIAN THERAPEUTICS INC -- $9,234.00 1,215 BQB9HM8
0.01% CCCC C4 THERAPEUTICS INC -- $8,908.32 3,324 BKX9NQ0
0.01% MXCT MAXCYTE INC -- $8,713.25 4,979 BKMQF66
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $8,622.40 1,268 BKC9SX3
0.01% CDXS CODEXIS INC -- $7,334.10 4,215 B5LL2C2
0.01% MRSN MERSANA THERAPEUTICS INC -- $6,416.82 233 BVPKH99
0.01% ALEC ALECTOR INC -- $6,381.45 4,727 BJ4LDC4
0.01% NKTX NKARTA INC -- $6,070.11 3,317 BK80YJ8
0.01% FATE FATE THERAPEUTICS INC -- $5,924.60 5,386 BCZS820
0.01% CLYM CLIMB BIO INC -- $5,823.60 3,165 BMW5LX6
0.01% PLRX PLIANT THERAPEUTICS INC -- $4,529.86 2,867 BMDWW66
0.01% TVGN TEVOGEN BIO HOLDINGS INC -- $4,418.47 9,186 BPG5P75
-- MGNX MACROGENICS INC -- $4,368.96 2,952 BFDV8K0
-- ARTV ARTIVA BIOTHERAPEUTICS INC -- $4,084.78 1,141 BMF1LJ7
-- STRO SUTRO BIOPHARMA INC -- $3,508.86 3,959 BF12XC2
-- ACRV ACRIVON THERAPEUTICS INC -- $3,466.84 1,469 BP2TPK4
-- BMEA BIOMEA FUSION INC -- $2,973.53 2,779 BNKF6N0
-- TCRX TSCAN THERAPEUTICS INC -- $2,719.50 2,450 BNLYBJ7
-- APLT APPLIED THERAPEUTICS INC -- $1,776.75 6,725 BJL38Z1
-- OKUR ONKURE THERAPEUTICS INC-A -- $1,716.00 600 BT7KGT6
-- QTTB Q32 BIO INC -- $1,172.14 569 BS2FKQ4
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
40.08% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 35,125,469 -- 6,042 --
33.80% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 29,625,851 -- 5,096 --
22.74% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 19,928,849 -- 3,428 --
16.48% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 14,440,858 -- 2,484 --
15.25% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 13,365,351 -- 2,299 --
4.20% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 3,679,977 -- 633 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $28,358,204.20 28,358,204 --

Index

as of 9/30/2025

  • Total Number of Companies251
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.56 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.